Clin2
NCT06252961Possibly a fitRecruiting

Testing levamisole for loiasis infection

Loiasis

Part of Infections, Skin clinical trials.

This trial tests if a medicine called levamisole can safely reduce the number of loiasis (eye worm) parasites in your blood. You would take the medicine for 3 to 5 days and be monitored.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
99 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have a confirmed loiasis infection with Loa loa microfilariae in your blood.
  • Be between 18 and 65 years old.
  • Weigh between 40 kg (88 lbs) and less than 90 kg (198 lbs).
  • Be generally healthy with no recent or ongoing infections.
  • Not be pregnant, breastfeeding, or planning to become pregnant.
  • You cannot have taken ivermectin or levamisole in the last 6 months, or mebendazole/albendazole in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06613997Not yet recruiting· Phase 3
Testing albendazole for Loa Loa infection

This trial tests if albendazole can lower the number of Loa Loa worms (microfilariae) in your blood. You will take a pill daily for 21 days, and researchers will monitor how well it works and how safe it is.

NCT06350851Recruiting
New rapid test to help end river blindness

This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.

Yaoundé
NCT06997159Not yet recruiting· Phase 2
Testing two oral treatments for cutaneous leishmaniasis

This study tests two new oral medicines compared to an existing oral medicine for people with a first episode of cutaneous leishmaniasis (skin sores caused by a parasite). It aims to find a more effective and convenient treatment.

Manaus, Amazonas
NCT06514560Recruiting
Optimizing miltefosine treatment for leishmaniasis patients

This trial tests how well miltefosine works for people with leishmaniasis, a skin infection from a parasite. It aims to find the best way to use this medicine to help patients get better.

Addis Ababa
NCT07463040Not yet recruiting· Phase 3
Comparing treatments for cutaneous leishmaniasis

This study tests different drugs to find which works best for cutaneous leishmaniasis (a skin infection from a parasite). It may help people with many or large sores, or sores in sensitive areas like near the eyes or nose.

Addis Ababa
NCT07657143Not yet recruiting· Phase 4
Ivermectin to stop flies that cause trachoma

This study checks if taking ivermectin pills can reduce the number of flies that spread trachoma, an eye infection. If you are healthy and between 18 and 65, you may help test whether this common parasite drug can also prevent trachoma.

London

Hear when a new Loiasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.